Â¥
10.13
May 17
New Key Statistics Module, Z-Score and F-Score
SZSE:002399 Key Ratios
Market Cap ¥ M | 13,378.98 |
Enterprise Value ¥ M | 15,819.15 |
P/E(ttm) | -- |
PE Ratio without NRI | 144.71 |
Forward PE Ratio | -- |
Price/Book | 1.23 |
Price/Sales | 2.69 |
Price/Free Cash Flow | 14.25 |
Price/Owner Earnings | -- |
Payout Ratio % | 1.43 |
Revenue (TTM) ¥ M | 5,517.00 |
EPS (TTM) ¥ | -0.47 |
Beneish M-Score | -3.03 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -170.90 |
EV-to-EBIT | -25.60 |
EV-to-EBITDA | -25.60 |
PEG | -- |
Shares Outstanding M | 1,467.30 |
Net Margin (%) | -12.59 |
Operating Margin % | 13.55 |
Pre-tax Margin (%) | -14.95 |
Quick Ratio | 0.89 |
Current Ratio | 2.26 |
ROA % (ttm) | -3.49 |
ROE % (ttm) | -5.68 |
ROIC % (ttm) | 3.96 |
Dividend Yield % | 0.99 |
Altman Z-Score | 2.01 |
SZSE:002399 Number of Guru Trades
SZSE:002399 Volume of Guru Trades
Gurus Latest Trades with SZSE:002399
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002399 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shenzhen Hepalink Pharmaceutical Group Co Ltd Insider Transactions
No Available Data